Cathepsin L Inhibition Prevents Murine Autoimmune Diabetes via Suppression of CD8+ T Cell Activity
Open Access
- 22 September 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (9), e12894
- https://doi.org/10.1371/journal.pone.0012894
Abstract
Type 1 diabetes (T1D) is an autoimmune disease resulting from defects in central and peripheral tolerance and characterized by T cell-mediated destruction of islet β cells. To determine whether specific lysosomal proteases might influence the outcome of a T cell–mediated autoimmune response, we examined the functional significance of cathepsin inhibition on autoimmune T1D-prone non-obese diabetic (NOD) mice. Here it was found that specific inhibition of cathepsin L affords strong protection from cyclophosphamide (CY)-induced insulitis and diabetes of NOD mice at the advanced stage of CD8+ T cell infiltration via inhibiting granzyme activity. It was discovered that cathepsin L inhibition prevents cytotoxic activity of CD8+ T cells in the pancreatic islets through controlling dipeptidyl peptidase I activity. Moreover, the gene targeting for cathepsin L with application of in vivo siRNA administration successfully prevented CY-induced diabetes of NOD mice. Finally, cathepsin L mRNA expression of peripheral CD8+ T cells from NOD mice developing spontaneous T1D was significantly increased compared with that from control mice. Our results identified a novel function of cathepsin L as an enzyme whose activity is essential for the progression of CD8+ T cell-mediated autoimmune diabetes, and inhibition of cathepsin L as a powerful therapeutic strategy for autoimmune diabetes.This publication has 51 references indexed in Scilit:
- Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouseJournal of Autoimmunity, 2010
- Drak2 overexpression results in increased β‐cell apoptosis after free fatty acid stimulationJournal of Cellular Biochemistry, 2008
- Translational Mini-Review Series on Type 1 Diabetes: Systematic analysis of T cell epitopes in autoimmune diabetesClinical and Experimental Immunology, 2007
- The role of cystatins in cells of the immune systemFEBS Letters, 2006
- Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune diseaseImmunological Reviews, 2006
- Cathepsin L is essential for onset of autoimmune diabetes in NOD miceJCI Insight, 2005
- In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- Cathepsin L Regulates CD4+ T Cell Selection Independently of Its Effect on Invariant ChainThe Journal of Experimental Medicine, 2002
- Splenic Cathepsin L Is Maturated from the Proform by Interferon-γ after Immunization with Exogenous AntigensBiochemical and Biophysical Research Communications, 2001
- Inhibition Mechanism of Cathepsin L-Specific Inhibitors Based on the Crystal Structure of Papain–CLIK148 ComplexBiochemical and Biophysical Research Communications, 1999